关于CAR T细胞在自身免疫性疾病中的潜力
Johanna Richter1, Martin Krusche2, Isabell Haase2
1Department for Stem Cell Transplantation, University Medical Center Hamburg, Hamburg, Germany.
Immunotherapy
|October 23, 2025
概括
化学抗原受体 (CAR) T细胞疗法对自身免疫性疾病具有前景,比目前的治疗方法提供更深层次的B细胞枯竭. 早期研究表明耐受性良好,并且在耐火病例中有令人鼓舞的反应.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞疗法细胞疗法
- 自身免疫性疾病的治疗方法
背景情况:
- 卡尔-T细胞疗法是自身免疫性疾病的新兴治疗方式.
- 它比单克隆抗体具有优势,包括更深层次的B细胞枯竭和组织透.
- 现有的数据表明,治疗耐火性自身免疫性疾病的潜力.
研究的目的:
- 审查在自身免疫性疾病中使用CAR T细胞治疗的理由.
- 总结当前关于CAR T细胞治疗自身免疫性疾病的临床数据.
- 突出这一领域的未来研究方向和前景.
主要方法:
- 对自身免疫性疾病中CAR T细胞疗法的现有文献的综述.
- 从病例报告和I/II期研究中分析早期临床数据.
- 探索不同的CAR T细胞结构 (例如CD19,BCMA,双准).
主要成果:
- 卡尔-T细胞疗法在患有严重,不耐药的自身免疫性疾病的患者中显示出令人鼓舞的临床反应.
- 针对CD19,BCMA和双重目标的构造通常被很好地容忍.
- 在早期的研究中观察到有限的安全问题.
结论:
- 卡尔-T细胞疗法是对自身免疫性疾病的有希望的方法,提供增强的B细胞枯竭.
- 需要进一步的研究来扩大适应症并优化CAR T细胞结构的有效性和安全性.
- 这种疗法具有很大的潜力,可以促进自身免疫性疾病的治疗.
相关概念视频
Autoimmune Disorders
1.5K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
1.5K
T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cell-mediated Immune Responses
83.4K
Overview
83.4K
T Cell Activation and Clonal Selection
14.7K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.7K
Cytotoxic T Cells-mediated Immune Response
6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K


